Value proposition

Innovating vaccines to reduce human diseases.
Part of Utrecht Science Park Bilthoven


Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development.
We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies.
As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans.
Part of Utrecht Science Park Bilthoven

Vaccinology, Healthcare, R&D, and Platform Technology